Cytochrome P450 21A2 (CYP21A2) Genotyping
CYP21A2 is polypeptide 2 within the A subfamily, in the 21 family of CYP450. It is coded by the CYP21A2 gene located on chromosome 6p21.3 and encodes the 21-hydroxylase enzyme, which is required for the synthesis of steroid hormones such as cortisol and aldosterone, as well as a nonfunctional pseudogene. Absence or malfunction of this gene is the leading cause for the autosomal recessive disorder congenital adrenal hyperplasia (CAH) through the buildup of the intermediates progesterone and 17-hydroxyprogesterone. This ultimately leads to reduced synthesis of cortisol.
There are 181 alleles that have been identified. Among them, *9 (splicing mutation In2) is the most prevalent mutation in all ethnic groups. It causes salt wasting (SW) type CAH; *7 (deletions of CYP21A2), *10 (deletion of 8 bp), *17 (Q318Stop), and *18 (R356W) are also the highly prevalent mutations that cause SW; *8 (single point missense mutation P30L) normally causes non-classic CAH; *11 (I172N) is the most commonly identified mutation that causes simple-virilizing (SV) CAH. Conversion events between CYP21A2 and its pseudogene CYP21A1P are often the cause of disease causing mutations.
- Diagnosis of 21-hydroxylase deficient congenital adrenal hyperplasia
- Carrier screening for 21-hydroxylase deficient congenital adrenal hyperplasia
- As an aid in diagnosis of 21-hydroxylase deficient CAH when a common mutation panel is negative or only identifies 1 mutation
Single, non-mutated copies of CYP21A2 correctly synthesize the steroid hormones cortisol and aldosterone.
Whole blood collected in lavender top tube (EDTA) or any anticoagulant collection devices. Buccal swab is also used.
Stability
- Ambient: 5 days
- Refrigerated: 7 days
- Clin Genet. 2001 May;59(5):293-301. [PMID: 11359457]
- Am J Pharmacogenomics. 2001;1(2):101-10. [PMID: 12174671]
- Clin Genet. 2001 May;59(5):293-301. [PMID: 11359457]
- BMC Endocr Disord. 2011;11:5. [PMID: 21329531]